4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-070325
Chief Medical Officer sold 5,000 shares at an average $50.72 ($253,608)
- Chief Medical Officer acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2021-12-15 | Option exercise | +5,000 | $1.53 | $7,650 | 97,777 | D: show line 1 in the form |
| Pang Phillip Chief Medical Officer | 2021-12-15 | Sale | −1,716 | $49.41 | $84,795 | 96,061 | D: show line 2 in the form |
| Pang Phillip Chief Medical Officer | 2021-12-15 | Sale | −1,050 | $50.60 | $53,133 | 95,011 | D: show line 3 in the form |
| Pang Phillip Chief Medical Officer | 2021-12-15 | Sale | −1,034 | $51.30 | $53,040 | 93,977 | D: show line 4 in the form |
| Pang Phillip Chief Medical Officer | 2021-12-15 | Sale | −1,200 | $52.20 | $62,640 | 92,777 | D: show line 5 in the form |
| Open-market sales · 5,000 sh · avg $50.72 · $253,608 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2021-12-15 | Option exercise · Stock Option (Right to Buy) | −5,000 | 72,591 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…